Management of imatinib-resistant patients with chronic myeloid leukemia.
about
A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathwayImatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategyThe CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.[Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib]Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase.BIRC6 mediates imatinib resistance independently of Mcl-1.EM23, A Natural Sesquiterpene Lactone from Elephantopus mollis, Induces Apoptosis in Human Myeloid Leukemia Cells through Thioredoxin- and Reactive Oxygen Species-Mediated Signaling Pathways.ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis.Computational and mechanistic studies on the effect of galactoxyloglucan: Imatinib nanoconjugate in imatinib resistant K562 cells.Dynamics of Expression of Drug Transporters: Methods for Appraisal.Overexpression of Hiwi Inhibits the Cell Growth of Chronic Myeloid Leukemia K562 Cells and Enhances Their Chemosensitivity to Daunomycin.miRNAs in chronic myeloid leukemia: small molecules, essential function.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.Pancytopenia during tyrosine kinase inhibitor treatment - coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report.Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib.Nilotinib after imatinib first-line: a real-life longitudinal cohort of patients with chronic myeloid leukaemia in chronic phase.Overexpression of miR-202 re-sensitizes imatinib resistant chronic myeloid leukemia cells through targeting Hexokinase 2 (HK2).Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response.Evaluation of the potential synergism of imatinib-related poly kinase inhibitors using growth factor stimulated proteoglycan synthesis as a model response.
P2860
Q28649477-E55FA3B0-85AC-45F8-8735-DE4B4A149C14Q30008882-3AD17C81-1828-4CB5-8503-A4B2460B4113Q33688509-94733E3F-CD8F-4FF8-BCE8-3CC02696C451Q34539293-E84FC4C2-7025-4E2E-A01C-2DFAA4AA61E5Q34978247-8581B254-6B21-43D3-94EB-379747546F08Q36184500-68BCB2E8-1DED-41E2-A9BB-7190CB6E606CQ36375641-0003EF69-97D4-46A1-BBC0-24848E3F1B36Q36734783-8A70BF2B-084F-451B-BBF8-438B4C891402Q38253243-08E039BC-7EF4-41E7-BAFD-6B98426408ECQ38710404-8C6F93A1-636B-4BD4-8A91-A278DF588688Q38791448-5B04619A-E2AB-4D3A-A0C5-1E76439B1B8DQ38907442-E616F177-DD61-4F38-9C92-6CD421472806Q38979577-8BC36FDD-0AC8-4245-ABA6-7A82893831DCQ39429836-A98260B3-B0A2-463B-946E-E3DCEE400F74Q40598681-2E7FEA6A-DBE3-4337-8D29-EC3D84F0F0CAQ47122831-92EC57CF-58D7-45FC-8812-44327981926EQ47300241-C02E267B-145B-46D9-A30A-3F1BDC65B102Q52646158-99D84F2D-25B5-46B4-BEFF-A0BE241DCF37Q53728563-91C643FF-5187-496C-A7CF-0FB619EF0479Q54214231-91EDEEFC-3536-4EFD-9DD7-EDA70ACF6A24
P2860
Management of imatinib-resistant patients with chronic myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Management of imatinib-resistant patients with chronic myeloid leukemia.
@ast
Management of imatinib-resistant patients with chronic myeloid leukemia.
@en
type
label
Management of imatinib-resistant patients with chronic myeloid leukemia.
@ast
Management of imatinib-resistant patients with chronic myeloid leukemia.
@en
prefLabel
Management of imatinib-resistant patients with chronic myeloid leukemia.
@ast
Management of imatinib-resistant patients with chronic myeloid leukemia.
@en
P2860
P50
P356
P1476
Management of imatinib-resistant patients with chronic myeloid leukemia.
@en
P2093
A Megan Cornelison
Pavan Kumar Bhamidipati
P2860
P304
P356
10.1177/2040620712468289
P577
2013-04-01T00:00:00Z